These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14059845)

  • 1. PLASMA CHANGES DURING FIBRINOLYTIC THERAPY.
    JOHNSON JF; BARNHART MI; GILROY J; MEYER JS
    Vox Sang; 1963; 8():484-8. PubMed ID: 14059845
    [No Abstract]   [Full Text] [Related]  

  • 2. FIBRINOLYSIS AND FIBRINOLYTIC AGENTS IN CLINICAL PRACTICE. (WITH SPECIAL REFERENCE TO STREPTOKINASE).
    JAMES DC; BROWSE NL
    Br J Clin Pract; 1964 Jun; 18():343-56. PubMed ID: 14169065
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 4. [THERAPEUTIC FIBRINOLYSIS. II. STUDIES ON THE EFFICACY OF STREPTOKINASE AND ACTASE IN VIVO].
    JUERGENS J
    Klin Wochenschr; 1964 Jun; 42():539-46. PubMed ID: 14233282
    [No Abstract]   [Full Text] [Related]  

  • 5. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 6. THROMBOLYTIC THERAPY.
    FLUTE PT
    J Clin Pathol; 1964 May; 17(3):333-5. PubMed ID: 14159475
    [No Abstract]   [Full Text] [Related]  

  • 7. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 8. EXPERIMENTAL STUDIES ON THE PRODUCTION AND PREVENTION OF CEREBRAL INFARCTION IN DOGS.
    HANDA J
    J Neuropathol Exp Neurol; 1964 Jul; 23():457-76. PubMed ID: 14193252
    [No Abstract]   [Full Text] [Related]  

  • 9. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763
    [No Abstract]   [Full Text] [Related]  

  • 10. ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE.
    MEYER JS; GILROY J; BARNHART MI; JOHNSON JF
    JAMA; 1964 Aug; 189():373. PubMed ID: 14163124
    [No Abstract]   [Full Text] [Related]  

  • 11. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
    ADAMIS DM; MANIATIS GM
    Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
    [No Abstract]   [Full Text] [Related]  

  • 12. [ON THE MECHANISM OF ACTION OF FIBRINOLYTIC SUBSTANCES].
    ROSOLLECK H
    Thromb Diath Haemorrh; 1963 Jul; 143():459-71. PubMed ID: 14081267
    [No Abstract]   [Full Text] [Related]  

  • 13. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON THE ACTION OF THROMBOLYTIC DRUGS].
    PATEL J; CORMIER JM
    Mem Acad Chir (Paris); 1964 Jun; 90():628-30. PubMed ID: 14179177
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases.
    DEWAR HA; STEPHENSON P; HORLER AR; CASSELLS-SMITH AJ; ELLIS PA
    Br Med J; 1963 Apr; 1(5335):915-20. PubMed ID: 14027424
    [No Abstract]   [Full Text] [Related]  

  • 16. RADIOACTIVE (I-125) HUMAN PLASMA CLOTS FOR ASSAY OF THROMBOLYTIC ACTIVITY.
    HUME M
    J Lab Clin Med; 1964 Apr; 63():699-702. PubMed ID: 14155458
    [No Abstract]   [Full Text] [Related]  

  • 17. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.
    HAWKEY C; HOWELL M
    J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRESENT STATUS OF THROMBOLYTIC THERAPY.
    JOHNSON AJ
    Am Heart J; 1964 Mar; 67():418-20. PubMed ID: 14129234
    [No Abstract]   [Full Text] [Related]  

  • 19. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 20. The combined use of fibrinolytic and anticoagulant agents. Laboratory and clinical considerations.
    MOSER KM; HAJJAR GC
    Am J Cardiol; 1960 Aug; 6():496-502. PubMed ID: 13773043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.